This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Hidenorii Ogawa: Innovator in Cataract Treatment
Introduction
Hidenorii Ogawa is a notable inventor based in Itano-gun, Japan. He has made significant contributions to the field of ophthalmology, particularly in the prevention and treatment of cataracts. His innovative work has led to the development of a patented agent that addresses this common eye condition.
Latest Patents
Hidenorii Ogawa holds a patent for an "Agent for prophylaxis or treatment of cataract." This patent represents his commitment to advancing medical science and improving patient outcomes in eye health. The patent showcases his expertise and dedication to finding effective solutions for cataract management.
Career Highlights
Ogawa is associated with Otsuka Pharmaceutical Company, Limited, where he has been able to leverage his skills and knowledge in a collaborative environment. His work at Otsuka has allowed him to focus on research and development, contributing to the company's mission of enhancing healthcare through innovative products.
Collaborations
Throughout his career, Hidenorii Ogawa has collaborated with esteemed colleagues such as Shigeki Nakamura and Toshiyuki Onogawa. These partnerships have fostered a creative atmosphere that encourages the exchange of ideas and the pursuit of groundbreaking research in the field of ophthalmology.
Conclusion
Hidenorii Ogawa's contributions to cataract treatment exemplify the impact of innovation in healthcare. His dedication to research and collaboration continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile